Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Insilico Medicine
MedTech
Insilico pens potential $888M cancer R&D pact with Servier
Right on the heels of its IPO, Insilico Medicine is starting the year with an oncology discovery and development pact with French pharma Servier.
Ben Adams
Jan 4, 2026 7:30pm
Insilico Medicine aims to generate nearly $300M in Hong Kong IPO
Dec 18, 2025 11:17am
Lilly continues AI push, inking $100M-plus deal with Insilico
Nov 10, 2025 9:00am
Insilico Medicine nets $110M for new trials, robotic helpers
Mar 12, 2025 11:00am
Insilico posts benchmarks from 22 AI-designed drug candidates
Feb 11, 2025 9:00am
Insilico Medicine, Menarini sign second $500M+ cancer drug deal
Jan 10, 2025 9:30am
